News Wire ~ 3rd Party Press Release
Aimmune to Begin Phase 2 Trials of Egg Allergy OIT Candidate
AR201 for Egg Allergy Phase 2 Initiation Planned for 2019.
Test is 87% Accurate at Determining Outcome to Milk OIT
Using a growing database of patient reactivity signatures can better predict milk-allergic patient outcomes compared to traditional methods.
Probiotic Gives Long-Standing Protection Against Childhood Eczema, Study Finds
Giving a probiotic supplement to pregnant mothers and their infants significantly reduces the chances of a child developing eczema for the first 11 years of their life, researchers have shown.
Prevalence of Food Allergy and Access to Epinephrine for Children in the US
In this nationally representative household survey, parents were asked about their children’s food allergies, health care, and possession of an epinephrine auto-injector.
New Treatment to Protect People with Peanut Allergies Ready for FDA Review
"Two thirds of the people in the study were able to tolerate the equivalent of two peanuts per day after 9 to 12 months of treatment."
Severe Eczema May Best Be Treated by Allergy Shots
Significant benefits seen in one medically challenging case.
Using Mice, Duke Researchers Identify How Allergic Shock Occurs So Quickly
A newly identified immune cell mines the blood for allergens to directly trigger inflammation.
Mount Sinai and AllerGenis Announce Partnership to Bring Novel, Precision Diagnostics to Food Allergy...
The technology will provide an improved method for detecting, assessing, and monitoring food allergies in patients.
FDA Alert: Some EpiPen Auto-Injectors May Not Readily Slide Out of Carrier Tube
In some cases, the patient or caregiver may not be able to quickly remove the epinephrine auto-injector from the carrier tube.
Mount Sinai Researchers Find Wheat Oral Immunotherapy to Be Therapeutic for Allergic Patients
First multicenter rigorous clinical trial yields promising results.
